Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Paternity Questions About Michael Jackson's Kids Shine Light On Embryo Donation/Adoption
Entangled in all the controversial drama surrounding the sudden death of Pop-Icon Michael Jackson is the issue of his three children"s paternity. With conflicting facts out there, many people are talking about the possibility that his children may have been born through embryo donation and adoption. This practice is not new. Many families are successfully birthing healthy babies from frozen embryos throughout the United States.

Increased Fighting Makes Humanitarian Work, Health Situation More Difficult In Somalia, U.N. Says
Despite increasing danger posed by "al Qaeda-linked militants," U.N. Emergency Relief Coordinator John Holmes said Tuesday U.N. aid workers "were not backing away" from the country, Reuters reports. "Intense fighting is making it increasingly difficult to deliver aid in the Horn of Africa country, where U.N. agencies are trying to combat cholera outbreaks and maintain food supplies to 3.5 million hungry people," the news service writes (Nebehay, 7/21).
News of the day
Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks
An innovative treatment for infections of the respiratory tract in cystic fibrosis patients has received a second orphan drug designation in the US only weeks after a first designation was granted. The recent designation relates to Burkholderia cepacia pathogens that can cause lethal infections in cystic fibrosis patients. For Axentis Pharma AG of Zurich, Switzerland, both designations affirm the therapeutic potential of its product candidate Fluidosomes(TM)-tobramycin, whose unique microbiological profile sets it apart from other antibiotic formulations (including free tobramycin).
Health Insurance

Prominent Bioinformatics Expert To Join Harvard School Of Public Health Faculty And Become Chair Of Dana-Farber Department Of Biostatistics

Giovanni Parmigiani, PhD, a noted leader in applying bioinformatics tools to cancer studies and medical decision-making, has been appointed professor of biostatistics at Harvard School of Public Health (HSPH) and as chair of the Department of Biostatistics and Computational Biology at Dana-Farber Cancer Institute. Parmigiani comes from Johns Hopkins University, where he was director of the Cancer Center"s Bioinformatics Shared Re and a professor in the Departments of Oncology and Biostatistics. Parmigiani"s HSPH and Dana-Farber appointments are effective Sept. 1. Parmigiani"s principal research interest is the development of statistical and computational methods to capture and assess biomedical data, including models and software for predicting a person"s risk of cancer. He has helped devise a number of bioinformatics software tools and programs, including BRCAPRO, which is used in genetic counseling of families at high risk of breast and ovarian cancer, and BayesMendel, a suite of tools that covers a broad range of familial risk prediction tasks in breast, ovarian, colorectal, and pancreatic cancers. "Cancer claims the lives of millions of people around the world," said James H. Ware , PhD, Dean for Academic Affairs and Frederick Mosteller Professor of Biostatistics at HSPH. "We need every tool in our arsenal to fight this disease. Dr. Parmigiani"s tremendous talents in bioinformatics will add to our growing ability to prevent cancer and to save lives." "Dr. Parmigiani is an extraordinarily gifted scientist and a widely regarded leader in the use of bioinformatics to study genetic risk in cancer and to assess genomic data on the effectiveness of therapies studied in clinical trials," said Edward J. Benz, Jr., MD, president of Dana-Farber. "Utilizing the latest biostatistical and computational methodologies to improve how we design cancer studies and collect and analyze the information they generate is a critical step in the development of more effective and more patient-tailored cancer treatments." Parmigiani earned his doctoral degree in statistics from Carnegie Mellon University in Pittsburgh. He is the author of more than 150 books, book chapters, and scientific papers and is a member of several professional societies. He is a fellow of the American Statistical Association. Prior to Johns Hopkins, Parmigiani held faculty positions at Duke University. Harvard School of Public Health


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009